Abstract:BACKGROUND:Receptor activator of nuclear factor κB ligand(RANKL) plays an important role in differentiation,activation,and survival of osteoclast.Osteoprotegerin(OPG),which acts as a decoy receptor of RANKL,suppresses the differentiation,inhibits activation and induces apoptosis of osteoclasts.OBJECTIVE:To investigate time-course changes of RANKL,OPG mRNA,and protein expression and bone mineral density(BMD) of ovariectomized rats.DESIGN,TIME AND SETTING:The randomized controlled animal experiment was performed at in the Laboratory of Transplantation Immunity of West China Hospital,Sichuan University from May to October 2006.MATERIALS:Fifty healthy,female,Sprague Dawley rats with 6-month-old,weighting 300 g-320 g were selected,and were randomly averagely divided into the ovariectomized and control groups.METHODS:The model ovariectomized rat was established.Condyles of femurs were obtained at weeks 2,4,6,8,10 after ovariectomy.MAIN OUTCOME MEASURES:BMD,RANKL,protein expression and the levels of OPG mRNA in condyles of femur.RESULTS:The femoral condyles BMD in the ovariectomized group was significantly lower than that in the control group since 6 weeks after operation(P < 0.05).The expression level of RANKL mRNA reached a peak at 4 weeks,and that of RANKL protein peaked at 6 weeks after operation,then both maintained at a high level.Compared with the control group,the statistical difference existed in the expression level at each time point(P < 0.05).The expression level of OPG mRNA in the ovariectomized group reached a peak at 4 weeks,and that of OPG protein peaked at 2 weeks after operation,and then both decreased rapidly.Compared with the control group,there had statistical difference in expression level at each time point after operation(P < 0.05).CONCLUSION:The femoral condyles BMD is sensitive to ovariectomy.The expression level of RANKL maintains at high level and that of OPG increases transiently and decreases rapidly,which is the direct reason of osteoporosis.

Role of Receptor Activator of Nuclear Factor Kappa B Lignand in Bone Resorption Caused by Ameloblastoma

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

The Role of RANKL and MMP-9 in the Bone Resorption Caused by Ameloblastoma

Expression and significance of receptor activator of nuclear factor kappa B-ligand in ameloblastoma

Mineralizing Solution and Dexamethasone Enhance Receptor Activator for NF-κB Ligand Expression in Rat Bone Marrow Stromal Cells

The Expression and Significance of RANKL,MMP-9 and MMP-2 in Ameloblastoma

The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

Upregulation of Interleukin-8 and Activin A Induces Osteoclastogenesis in Ameloblastoma

Study on the Mechanism of RANKL in Bone Absorption of Periapical Lesion

The Role of RANKL in Bone Remodeling

[Osteoclast Differentiation Regulated by Receptor Activator of Nuclear Factor Kappab Probably Through a Novel Signaling Pathway].

In vivo Application of Amelogenin Suppresses Root Resorption

Expression and quantitative analysis of RANKL in normal periodontal tissue of rats

Progress in Research of R ANKL/RANK Pathway and Its Regulation in Root and Alveolar Bone Resorption During the Replacement of Primary and Permanent Teeth

RANKL-independent modulation of osteoclastogenesis

Expression and Significance of Receptor Activator of Nuclear Kb Ligand in Odontogenic Keratocyst

[In Vitro Study on Bone Resorption of Odontogenic Cysts and Ameloblastomas].

Upregulated Expression of Rankl on Bone Marrow Stromal Cells Can Stimulate Osteoclast Precursors to Mature into Functional Osteoclasts and Promote Survival of Myeloma Cells

Changes of receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in ovariectomized rats

TNF-family member Receptor Activator of NF-κB (RANK) and RANK-Ligand (RANKL) in bone remodelling

Expression of Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Ameloblastoma